Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Gary Harms shops for Roundup products at a store in San Rafael, California, on July, 9, 2018. Glyphosate, the active ingredient in Roundup, has been classified by the World Health Organization as a probable human carcinogen since 2015. (Photo: Josh Edelson/AFP/Getty Images)

Gary Harms shops for Roundup products at a store in San Rafael, California, on July, 9, 2018. Glyphosate, the active ingredient in Roundup, has been classified by the World Health Organization as a probable human carcinogen since 2015. (Photo: Josh Edelson/AFP/Getty Images)

'Historic Victory': Bayer to End US Residential Sales of Glyphosate-Based Herbicides

"As agricultural, large-scale use of this toxic pesticide continues, our farmworkers remain at risk. It's time for EPA to act and ban glyphosate for all uses."

Kenny Stancil

In a move that environmental groups celebrated as a "historic victory" following years of campaigning to remove Roundup and similar weedkillers from store shelves, Bayer on Thursday announced that it will halt the sale of glyphosate-based herbicides to consumers in the U.S. lawn and garden market by 2023.

"Bayer's decision to end U.S. residential sale[s] of Roundup is a historic victory for public health and the environment," Andrew Kimbrell, executive director of the Center for Food Safety (CFS), said in a statement.

"As agricultural, large-scale use of this toxic pesticide continues," he added, "our farmworkers remain at risk. It's time for EPA to act and ban glyphosate for all uses."

While calling the announcement "an important victory to protect the health of Americans," Kendra Klein, senior scientist at Friends of the Earth, stressed that "action on this toxic weedkiller can't wait until 2023. Major home and garden retailers like Home Depot and Lowe's must lead the industry by ending the sales of Roundup immediately."

The key ingredient found in Roundup, the world's most widely used herbicide, is glyphosate. Described by the World Health Organization as "probably carcinogenic," glyphosate poses threats to human health and to pollinators such as bumblebees and monarch butterflies.

Bayer stated that it will switch Roundup and other glyphosate-based weedkillers to formulas that "rely on alternative active ingredients" in order to "manage litigation risk and not because of any safety concerns."

Thursday's decision came in response to several legal battles that Bayer, a German pharmaceutical and biotech corporation, inherited when it acquired Monsanto, a U.S. agrochemical giant and creator of Roundup, in 2018.

Last year, Bayer announced multiple massive settlements totaling more than $11 billion to compensate individuals harmed by two Monsanto herbicides.

In one case, the company agreed to pay $10.9 billion to about 125,000 people who alleged the use of Roundup was to blame for their cancer diagnoses.

The Roundup litigation settlement was preceded by three high-profile lawsuits, in which juries sided with plaintiffs suffering from non-Hodgkin lymphoma "in finding that their exposure to glyphosate contributed to their cancers," CFS explained. "Plaintiffs Edwin Hardeman, DeWayne Johnson, and Alberta and Alva Pilliod were each awarded between $25 to $87 million."

"Massive amounts of glyphosate will continue to be sprayed in parks, schools, and on food crops."
—Kendra Klein, Friends of the Earth

Two months ago, the U.S. Court of Appeals for the 9th Circuit in San Francisco affirmed a lower court ruling in Hardeman v. Monsanto, which found that Monsanto had failed to disclose the dangers glyphosate poses to human health and must be held accountable for the cancer suffered by users of Roundup.

By upholding the previous judgment against Monsanto, Kimbrell said at the time, the court "unanimously rejected Bayer's argument that Mr. Hardeman and thousands of others harmed by their products are prohibited by federal law from suing to redress their injuries."

In a separate settlement last year, Bayer agreed to pay $400 million to thousands of farmers whose crops had been damaged as a result of the widespread drift of Monsanto's dicamba herbicide. That agreement was preceded by two lawsuits that, according to CFS, "likely provided impetus for Bayer to settle."

In California, jury trials over Monsanto's Roundup and dicamba products continue to be held.

Meanwhile, CFS is also currently representing a coalition of farmworkers and environmentalists in a lawsuit that seeks to reverse the Environmental Protection Agency's approval of glyphosate, which was reviewed and registered in January 2020 by Trump administration officials.

While President Joe Biden's EPA admitted in May that the Trump-era assessment of glyphosate was flawed and requires a do-over, the agency failed to provide a deadline for a new decision and argued that Roundup should remain on U.S. shelves in the meantime.

Given that Bayer's decision to stop selling glyphosate-based herbicides by 2023 only applies to consumers in the U.S. lawn and garden market, Klein emphasized that "the battle against this toxic chemical is far from over."

"Massive amounts of glyphosate will continue to be sprayed in parks, schools, and on food crops," she added. "Retailers and regulators must act now to ban this cancer-linked weedkiller."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

British Court Rules Assange Can Appeal US Extradition

"As long as this case isn't dropped, as long as Julian isn't freed, Julian continues to suffer," said Stella Moris, Assange's fiancée.

Jake Johnson ·


Biden Considering Deploying Thousands of Troops to Eastern Europe

Anti-war commentators warned of an "exceedingly dangerous quagmire" in Ukraine if the U.S. ramps up its military presence in the region.

Jake Johnson ·


Leaked Report Suggests Impunity for IDF Troops in Deadly Stop of Palestinian-American Elder

"This is a policy: Israel does not prosecute those responsible for harming Palestinians, thus making their lives miserable," said the Israeli human rights group B'Tselem.

Brett Wilkins ·


'Exactly Right': Progressives Back Arizona Dems Censure of Sinema

"If you are a Democrat and you can't uphold the fundamental right to vote for all citizens... then there's a problem," said Rep. Ro Khanna.

Brett Wilkins ·


Amid Existential Threat to Reproductive Rights, Congress Urged to Act

"It's the 49th anniversary of Roe v. Wade, and if we don't fight like hell it could very well be the last," said one campaigner, who called on U.S. lawmakers to pass the Women's Health Protection Act.

Brett Wilkins ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo